1,320
Participants
Start Date
February 9, 2011
Primary Completion Date
March 18, 2013
Study Completion Date
March 18, 2013
Pneumococcal vaccine GSK 2189242A (LD formulation 1)
Intramuscular injection
Pneumococcal vaccine GSK 2189242A (HD formulation 2)
Intramuscular injection
Synflorix™
Intramuscular injection
Prevnar13™
Intramuscular injection
Tritanrix™-HepB/Hib
Intramuscular injection
Polio Sabin™
Orally
M-Vac™
Intramuscular injection
Stamaril™
Intramuscular injection
GSK Investigational Site, Banjul
Lead Sponsor
PATH
OTHER
Department of State for Health and Social Welfare, The Gambia
OTHER_GOV
Medical Research Council Unit, The Gambia
OTHER
London School of Hygiene and Tropical Medicine
OTHER
GlaxoSmithKline
INDUSTRY